, the world's second-largest economy. CHXF, which will charge 0.63 percent per year, will hold China-based companies that trade in Hong Kong. The new ETF will be a stark departure from the iShares ...

Day SEC Yield of 1.37% as of June. 24. Payable Jun 29; for shareholders of record Jun 25; ex-div Jun 25. More on WisdomTree True Emerging Markets Fund ETF Seeking Alpha’s Quant Rating on WisdomTree ...

The WisdomTree China ex-State-Owned Enterprises Fund targets high-growth non-SOE Chinese large caps, emphasizing IT, communications, and healthcare. CXSE has historically outperformed major China ETFs ...

Emerging market investors took notice recently when unexpected outflows were seen coming from several Chinese companies. A WisdomTree rebalance of its ex-state-owned-enterprise indexes with exposure ...

Day SEC Yield of 0.87% as of June. 24. Payable Jun 29; for shareholders of record Jun 25; ex-div Jun 25. More on WisdomTree China ex-State-Owned Enterprises Fund China unveils measures to boost green ...

WisdomTree (NYSE:WT) has launched the WisdomTree Asia Defense Fund (WDAF), an ETF focused on defense related companies across ...

WisdomTree China ex-State-Owned Enterprises Fund issues dividends to shareholders from excess cash WisdomTree China ex-State-Owned Enterprises Fund generates. Most companies pay dividends on a ...

It may be early in the year, but it’s possible we already may be seeing a key theme in China loosening its zero-COVID policies. As one of the world’s economic pillars, the country will be aiming to ...

In our view, as of mid-2026, it is the only coherent position for a fund aligned with U.S. defense and industrial policy. Read more here.

Investors are growing increasingly concerned that tensions between the U.S. and China make Chinese stocks too risky to rely ...

One of the persistent themes in the first half of 2026 has been international exposure. With potentially overstretched ...

This article was originally published on ETFTrends.com. Liqian Ren, Ph.D., and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D., co-founder and CEO of Adagene, regarding ...